Kolexia
Villalva-Gregoire Claire
Pharmacien
Hôpital La Miletrie
Poitiers, France
27 Activités
0 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs colorectales Gliome Métastase tumorale Tumeurs du cerveau Glioblastome Tumeurs du foie Carcinome pulmonaire à petites cellules Tumeurs du poumon Adénomes

Industries

AstraZeneca
4 collaboration(s)
Dernière en 2022
{{person.topindus2.name}}
{{person.topindus2.tot}} collaboration(s)
Dernière en {{person.topindus2.last}}
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Detection of Colorectal Cancer and Advanced Adenoma by Liquid Biopsy (Decalib Study): The ddPCR Challenge.
Cancers   06 juin 2020
Pathological and Molecular Characteristics of Colorectal Cancer with Brain Metastases.
Cancers   10 décembre 2018
Association between clinicopathological characteristics and RAS mutation in colorectal cancer.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc   20 octobre 2017
Crizotinib targets in glioblastoma stem cells.
Cancer medicine   27 septembre 2017
External quality assessment of EGFR testing in circulating DNA: a french pilot study
Abstract Book of the 41st ESMO Congress (ESMO 2016), 7-11 October 2016, Copenhagen, Denmark   01 octobre 2016
Abstract 1051: Activation of PI3K pathway in breast cancer associates with tumor phospholipid fatty acid composition
Proceedings: AACR 107th Annual Meeting 2016   15 juillet 2016
Development of pyrosequencing methods for the rapid detection of RAS mutations in clinical samples.
Experimental and molecular pathology   08 juillet 2015
A mesenchymal glioma stem cell profile is related to clinical outcome.
Oncogenesis   17 mars 2014
Epidermal growth factor receptor (EGFR) and KRAS mutations during chemotherapy plus anti-EGFR monoclonal antibody treatment in metastatic colorectal cancer.
Cancer chemotherapy and pharmacology   14 juin 2013
EGFR and KRAS mutations during anti-EGFR monoclonal antibody treatment in metastatic colorectal cancer: Clinically relevant?
2013 ASCO Annual Meeting I   20 mai 2013